Intent To Grant a Co-Exclusive Patent License, 23866 [05-8986]
Download as PDF
23866
Federal Register / Vol. 70, No. 86 / Thursday, May 5, 2005 / Notices
meetings of the WTC Expert Panel can
be found at the panel Web site.
ENVIRONMENTAL PROTECTION
AGENCY
SUMMARY: Pursuant to 35 U.S.C. 207
(Patents) and 37 CFR part 404 (U.S.
Government patent licensing
regulations), EPA hereby gives notice of
its intent to grant a co-exclusive,
royalty-bearing, revocable license to
practice the invention described and
claimed in the U.S. patent application
entitled Method for Isolating and Using
Fungal Hemolysins, filed May 30, 2001,
U.S. Serial Number 09/866,793, and all
corresponding patents issued
throughout the world, and all
reexamined patents and reissued
patents granted in connection with such
patent application, to Roche Diagnostics
Corporation, Indianapolis, Indiana, and
to Aerotech Laboratories, Phoenix,
Arizona.
The invention was announced as
being available for licensing in the May
12, 2003 issue of the Federal Register
(68 FR 25371) as U.S. Patent
Application Number 09/866,793, filed
May 30, 2001, and claiming priority
from a provisional application filed June
1, 2000.
The proposed co-exclusive license
will contain appropriate terms,
limitations, and conditions to be
negotiated in accordance with 35 U.S.C.
209 and 37 CFR 404.5 and 404.7 of the
U.S. Government patent licensing
regulations.
EPA will negotiate the final terms and
conditions and grant the co-exclusive
license, unless within 15 days from the
date of this notice EPA receives, at the
address below, written objections to the
grant, together with supporting
documentation. The documentation
from objecting parties having an interest
in practicing the above patents should
include an application for an exclusive
or nonexclusive license with the
information set forth in 37 CFR 404.8.
The EPA Patent Attorney and other EPA
officials will review all written
responses and then make
recommendations on a final decision to
the Director or Deputy Director of the
National Exposure Research Laboratory
who have been delegated the authority
to issue patent licenses under EPA
Delegation 1–55.
[FRL–7908–2]
DATES:
III. Hot To Get Information on EDOCKET
EPA has established an official public
docket for this action under Docket ID
No. ORD–2004–0003. The official public
docket consists of the documents
specifically referenced in this action,
any public comments received, and
other information related to this action.
Although a part of the official docket,
the public docket does not include
Confidential Business Information (CBI)
or other information whose disclosure is
restricted by statute. The official public
docket is the collection of materials that
is available for public viewing at the
Office of Environmental Information
(OEI) Docket in the Headquarters EPA
Docket Center, (EPA/DC) EPA West
Building, Room B102, 1301 Constitution
Avenue, NW., Washington, DC 20460.
The EPA Docket Center Public Reading
Room is open from 8:30 a.m. to 4:30
p.m., Monday through Friday, excluding
legal holidays. The telephone number
for the Public Reading Room is (202)
566–1744, and the telephone number for
the OEI Docket is (202) 566–1752;
facsimile: (202) 566–1753; or e-mail:
ORD.Docket@epa.gov.
An electronic version of the public
docket is available through EPA’s
electronic public docket and comment
system, EPA Dockets. You may use EPA
Dockets at https://www.epa.gov/edocket/
to submit or view public comments,
access the index listings of the contents
of the official public docket, and to
access those documents in the public
docket that are available electronically.
Once in the system, select ‘‘search,’’
then key in the appropriate docket
identification number.
Dated: April 28, 2005.
E. Timothy Oppelt,
Acting Assistant Administrator, EPA Office
of Research and Development.
[FR Doc. 05–8871 Filed 5–4–05; 8:45 am]
BILLING CODE 6560–50–M
Intent To Grant a Co-Exclusive Patent
License
Environmental Protection
Agency (EPA).
ACTION: Notice of intent to grant a coexclusive license.
AGENCY:
VerDate jul<14>2003
13:10 May 04, 2005
Jkt 205001
Comments on this notice must be
received by EPA at the address listed
below by May 20, 2005.
FOR FURTHER INFORMATION CONTACT:
Laura Scalise, Patent Attorney, Office of
General Counsel (Mail Code 2377A),
Environmental Protection Agency,
Washington, DC 20460, telephone (202)
564–8303.
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Dated: April 27, 2005.
Marla E. Diamond,
Associate General Counsel, Finance and
Operations Law Office.
[FR Doc. 05–8986 Filed 5–4–05; 8:45 am]
BILLING CODE 6560–50–P
EXPORT-IMPORT BANK
[Public Notice 75]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Export-Import Bank of the U.S.
Notice and request for
comments.
AGENCY:
ACTION:
SUMMARY: The Export-Import Bank of
the United States (Ex-Im Bank) provides
working capital guarantees to lenders. In
assessing the creditworthiness of an
applicant, Ex-Im Bank reviews EIB Form
84–1. This form provides information
which allows the Bank to obtain
legislatively required reasonable
assurance of repayment, as well as to
fulfill other statutory requirements. The
form has had some minor change in
content and requires a three-year
extension.
Written comments should be
received on or before July 5, 2005 to be
assured of consideration.
ADDRESSES: Direct all comments and
requests for additional information to
Pamela Bowers, Export-Import Bank of
the U.S., 811 Vermont Avenue, NW.,
Washington, DC 20571 (202) 565–3792,
or pamela.bowers@exim.gov.
SUPPLEMENTARY INFORMATION:
Titles and Form Numbers: U.S. Small
Business Administration, Export-Import
Bank of the United States Joint
Application for Working Capital
Guarantee.
OMB Number: 3048–0003.
Form Number: EIB–SBA 84–1
(Revised 2/2005).
Type of Review: Revision and
extension of expiration date.
Annual Number of Respondents: 600.
Estimated Time Per Respondent: 2
Hours.
Annual Burden Hours: 1,200.
Frequency of Reporting or Use: Upon
application for guarantees or working
capital loans advanced by the lenders to
U.S. exporters.
DATES:
Dated: April 29, 2005.
Solomon Bush,
Agency Clearance Officer.
BILLING CODE 6690–01–M
E:\FR\FM\05MYN1.SGM
05MYN1
Agencies
[Federal Register Volume 70, Number 86 (Thursday, May 5, 2005)]
[Notices]
[Page 23866]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-8986]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[FRL-7908-2]
Intent To Grant a Co-Exclusive Patent License
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice of intent to grant a co-exclusive license.
-----------------------------------------------------------------------
SUMMARY: Pursuant to 35 U.S.C. 207 (Patents) and 37 CFR part 404 (U.S.
Government patent licensing regulations), EPA hereby gives notice of
its intent to grant a co-exclusive, royalty-bearing, revocable license
to practice the invention described and claimed in the U.S. patent
application entitled Method for Isolating and Using Fungal Hemolysins,
filed May 30, 2001, U.S. Serial Number 09/866,793, and all
corresponding patents issued throughout the world, and all reexamined
patents and reissued patents granted in connection with such patent
application, to Roche Diagnostics Corporation, Indianapolis, Indiana,
and to Aerotech Laboratories, Phoenix, Arizona.
The invention was announced as being available for licensing in the
May 12, 2003 issue of the Federal Register (68 FR 25371) as U.S. Patent
Application Number 09/866,793, filed May 30, 2001, and claiming
priority from a provisional application filed June 1, 2000.
The proposed co-exclusive license will contain appropriate terms,
limitations, and conditions to be negotiated in accordance with 35
U.S.C. 209 and 37 CFR 404.5 and 404.7 of the U.S. Government patent
licensing regulations.
EPA will negotiate the final terms and conditions and grant the co-
exclusive license, unless within 15 days from the date of this notice
EPA receives, at the address below, written objections to the grant,
together with supporting documentation. The documentation from
objecting parties having an interest in practicing the above patents
should include an application for an exclusive or nonexclusive license
with the information set forth in 37 CFR 404.8. The EPA Patent Attorney
and other EPA officials will review all written responses and then make
recommendations on a final decision to the Director or Deputy Director
of the National Exposure Research Laboratory who have been delegated
the authority to issue patent licenses under EPA Delegation 1-55.
DATES: Comments on this notice must be received by EPA at the address
listed below by May 20, 2005.
FOR FURTHER INFORMATION CONTACT: Laura Scalise, Patent Attorney, Office
of General Counsel (Mail Code 2377A), Environmental Protection Agency,
Washington, DC 20460, telephone (202) 564-8303.
Dated: April 27, 2005.
Marla E. Diamond,
Associate General Counsel, Finance and Operations Law Office.
[FR Doc. 05-8986 Filed 5-4-05; 8:45 am]
BILLING CODE 6560-50-P